Xenon Pharmaceuticals Inc. Common Shares (XENE)

Stock · NASDAQ · Health Care

$59.99as of 8/28/2026

Price chart

Insider transactionsShow all transaction typesRevenue Growth

No technical signal is currently active for this symbol.

Support level

$54.59

Industry

Biotechnology: Pharmaceutical Preparations

Chosen by industry and closest market cap.

XENE
Xenon Pharmaceuticals Inc. Common Shares
$59.99
▼ 3.13%
Market cap $6.02BP/E —
BLTE
Belite Bio Inc American Depositary Shares
$151.65
▼ 3.42%
Market cap $6.09BP/E —
$62.18$200
ERAS
Erasca Inc. Common Stock
$18.03
▼ 7.49%
Market cap $6.11BP/E —
$1.33$24.28
LGND
Ligand Pharmaceuticals Incorporated Common Stock
$280
▼ 1.59%
Market cap $5.85BP/E 38.07
$158.4$326.63
DNTH
Dianthus Therapeutics Inc. Common Stock
$105.72
▼ 5.22%
Market cap $5.80BP/E —
$22.81$117.88
KNSA
Kiniksa Pharmaceuticals International plc Class A Ordinary Shares
$78.1
▼ 2.13%
Market cap $5.73BP/E 75.29
$33.25$82.94
PTCT
PTC Therapeutics Inc. Common Stock
$70.01
▼ 2.51%
Market cap $5.68BP/E —
$48.86$90.87

Symbol	Market cap	P/E ratio	Price	1D	52-week range
XENE Xenon Pharmaceuticals Inc. Common Shares	$6.02B	—	$59.99	▼ 3.13%
BLTE Belite Bio Inc American Depositary Shares	$6.09B	—	$151.65	▼ 3.42%	$62.18$200
ERAS Erasca Inc. Common Stock	$6.11B	—	$18.03	▼ 7.49%	$1.33$24.28
LGND Ligand Pharmaceuticals Incorporated Common Stock	$5.85B	38.07	$280	▼ 1.59%	$158.4$326.63
DNTH Dianthus Therapeutics Inc. Common Stock	$5.80B	—	$105.72	▼ 5.22%	$22.81$117.88
KNSA Kiniksa Pharmaceuticals International plc Class A Ordinary Shares	$5.73B	75.29	$78.1	▼ 2.13%	$33.25$82.94
PTCT PTC Therapeutics Inc. Common Stock	$5.68B	—	$70.01	▼ 2.51%	$48.86$90.87

P/E shows — for peers not currently carrying a live signal of their own.

March 31, 2026

Top holders this quarter

See the full, filterable feed with live charts on the MarketWall dashboard.